+1-888-308-5802     
News Contact Us

Foresite Labs to aid next-gen firms in Healthcare & Data Science

Author : Pankaj Singh | Published Date : 2019-11-02 

Foresite Labs, LLC, a company that incubates transformative firms at the interface of healthcare and data science, has recently revealed its public launch. According to reliable sources, the new company, which will be led by Dr. Vik Bajaj, Managing Director of Foresite Capital, combines statistical geneticists, experienced data scientists, biostatisticians, engineers and clinicians in creating and supporting early-stage healthcare firms.

Moreover, Foresite utilizes tools of data science such as industrialized understanding, experiment and measurement, to help resolve problems in healthcare and life sciences. Sources cite that Foresite incubated firms would profit from a data platform that consists of large proprietary and public data sets.

Also, the analysis platform includes scalable and mature tools from the world of causal inference and statistical genetics that allows analyses at a large-scale of primary human clinical and biological data, as well as uses solid implementations of budding methods based on artificial intelligence and machine learning.

Reportedly, Foresite’s experimental platform is strongly unified with its analysis platform and heavily counts on high-throughput clinical assessments and chemical & biological approaches. This would, in turn, benefit all its companies offering a strong and experienced technical, business leadership and scientific team.

Speaking on the announcement, Dr. Vik Bajaj said that their company’s understanding about the human disease was heavily influenced by population studies on a large scale that explores genetic basis of human biology by monitoring nature’s experiments.

Bajaj added that functional genomics’ techniques when coupled with advances in machine learning and computational biology would let the company associate its laboratory work with the clinical observations in extraordinary ways.

Meanwhile, Jim Tananbaum, Co-Founder of Foresite Labs and CEO of Foresite Capital, said that their firm is on the verge of transforming healthcare, following which there will be a modern healthcare system that efficiently serves the needs of the clinical consumer.
 

Source Credit: https://www.businesswire.com/news/home/20191031005909/en/Foresite-Labs-Launches-Incubate-Transformative-Companies-Data

About Author

Pankaj Singh

Pankaj Singh

Endowed with a post graduate degree in management and finance, Pankaj Singh has been a part of the online content domain for quite a while. Having worked previously as a U.K. insurance underwriter for two years, he now writes articles for fractovia.org and other online portals. He can be contacted at- [email protected] | https://twitter.com/PankajSingh2605

Related News

The Hop to deploy 35 smart kiosks to support streetcar operations

Published Date: 2020-02-22         Author: Pankaj Singh

The Hop, a modern fixed-transit network, has reportedly collaborated with Smart City Media LLC to execute a smart kiosk transport program that is developed to aid streetcar operations while promoting stronger networks between streetcar routes and key activity centers throughout the central business ... Read More

Qantas warns of a $99Mn financial impact due to coronavirus outbreak

Published Date: 2020-02-21         Author: Pankaj Singh

While most of the coronavirus instances have been observed in China, the global aviation industry is seen to be cautious about the dangerous virus. A new report from Qantas Airways Limited, an Australian airline has put some estimated numbers regarding the financial impacts of the coronavirus, ... Read More

Roche’s Tecentriq bags priority review for treating advanced NSCLC

Published Date: 2020-02-20         Author: Pankaj Singh

Swiss multinational pharmaceutical company, Roche has recently revealed that the U.S. FDA has acknowledged its sBLA (supplemental Biologics License Application) and approved Priority Review for Tecentriq® (atezolizumab) as an initial monotherapy for patients suffering from advanced NSCLC (non-sq... Read More

© 2020 Fractovia. All Rights Reserved